Snap shares surge 10% after longtime skeptic upgrades to buy – CNBC

Shares of social media company Snap rallied more than 10 percent Thursday after one longtime skeptic upgraded the stock and told clients that it’s set for outperformance thanks to better advertising sales. BTIG analyst Richard Greenfield now recommends investors buy the beat-up equity and thinks that the media sharing platform could see its shares soar…

Continue Reading →

Teva shares surge 5% on news of patent settlement with Neos over ADHD drug – MarketWatch

Shares of generic-drug maker Teva Pharmaceuticals Industries Ltd. rose about 5% Wednesday on news of a settlement and licensing agreement with Neos Therapeutics Inc. to resolve a patent dispute about a treatment for attention deficit disorders, or ADHD. Neos NEOS, -0.63% ┬ásaid the confidential agreement grants Teva TEVA, +8.43% ┬áthe right to make and market…

Continue Reading →